These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11021412)

  • 1. New developments in the pathophysiology, clinical spectrum, and diagnosis of disorders of fatty acid oxidation.
    Treem WR
    Curr Opin Pediatr; 2000 Oct; 12(5):463-8. PubMed ID: 11021412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sudden infant death syndrome and inherited disorders of fatty acid beta-oxidation.
    Harpey JP; Charpentier C; Paturneau-Jouas M
    Biol Neonate; 1990; 58 Suppl 1():70-80. PubMed ID: 2265221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy.
    Tein I
    J Child Neurol; 2002 Dec; 17 Suppl 3():3S57-82; discussion 3S82-3. PubMed ID: 12597056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: an investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years.
    Lundemose JB; Kølvraa S; Gregersen N; Christensen E; Gregersen M
    Mol Pathol; 1997 Aug; 50(4):212-7. PubMed ID: 9350306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life.
    Boles RG; Buck EA; Blitzer MG; Platt MS; Cowan TM; Martin SK; Yoon H; Madsen JA; Reyes-Mugica M; Rinaldo P
    J Pediatr; 1998 Jun; 132(6):924-33. PubMed ID: 9627580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition and management of fatty acid oxidation defects: a series of 107 patients.
    Saudubray JM; Martin D; de Lonlay P; Touati G; Poggi-Travert F; Bonnet D; Jouvet P; Boutron M; Slama A; Vianey-Saban C; Bonnefont JP; Rabier D; Kamoun P; Brivet M
    J Inherit Metab Dis; 1999 Jun; 22(4):488-502. PubMed ID: 10407781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIDS and disorders of fatty acid oxidation: where do we go from here?
    Cederbaum SD
    J Pediatr; 1998 Jun; 132(6):913-4. PubMed ID: 9627576
    [No Abstract]   [Full Text] [Related]  

  • 8. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.
    Ibdah JA; Bennett MJ; Rinaldo P; Zhao Y; Gibson B; Sims HF; Strauss AW
    N Engl J Med; 1999 Jun; 340(22):1723-31. PubMed ID: 10352164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disorders of fatty acid transport and mitochondrial oxidation: challenges and dilemmas of metabolic evaluation.
    Rinaldo P; Matern D
    Genet Med; 2000; 2(6):338-44. PubMed ID: 11339654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid oxidation disorder as a cause of sudden infant death syndrome (SIDS)--a case report.
    Thanka J; Padmasani ; Krishnan L; Kuruvilla S
    Indian J Pathol Microbiol; 2005 Oct; 48(4):485-7. PubMed ID: 16366103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial infantile apnea and immature beta oxidation.
    Iafolla AK; Browning IB; Roe CR
    Pediatr Pulmonol; 1995 Sep; 20(3):167-71. PubMed ID: 8545168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defects in mitochondrial fatty acid oxidation: clinical presentations and their role in sudden infant death.
    Pollitt RJ
    Padiatr Padol; 1993; 28(1):13-7. PubMed ID: 8446423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.
    Treem WR; Rinaldo P; Hale DE; Stanley CA; Millington DS; Hyams JS; Jackson S; Turnbull DM
    Hepatology; 1994 Feb; 19(2):339-45. PubMed ID: 8294091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
    Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
    Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations and management of fatty acid oxidation disorders.
    Merritt JL; MacLeod E; Jurecka A; Hainline B
    Rev Endocr Metab Disord; 2020 Dec; 21(4):479-493. PubMed ID: 32654032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological outcomes in fatty acid oxidation disorders: 85 cases detected by newborn screening.
    Waisbren SE; Landau Y; Wilson J; Vockley J
    Dev Disabil Res Rev; 2013; 17(3):260-8. PubMed ID: 23798014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial fatty acid oxidation disorders in Thai infants: a report of 3 cases.
    Wasant P; Matsumoto I; Naylor E; Liammongkolkul S
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S710-9. PubMed ID: 12403251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inborn errors of mitochondrial fatty acid oxidation.
    Vianey-Liaud C; Divry P; Gregersen N; Mathieu M
    J Inherit Metab Dis; 1987; 10 Suppl 1():159-200. PubMed ID: 3119938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inborn defects of fatty acid oxidation: a preventable cause of SIDS.
    Keppen LD; Randall B
    S D J Med; 1999 Jun; 52(6):187-8; disscussion 188-9. PubMed ID: 10388343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.